Orientoxin
Laiyang
About Orientoxin
Orientoxin specializes in therapeutics and reagents development from snake venoms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $433.9K
- Funding stage: Seed
- Last round: Angel (Nov 2016)
- Website: orientoxin.com
- Phone: 0535-7188656
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/orientoxin-2225984 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.